BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 4364538)

  • 21. Antibodies associated with Epstein-Barr virus in Burkitt's lymphoma during injections of BCG or irradiated autochthonous tumor cells.
    Gunvén P; Klein G; Onyango J; Henle G; Henle W; Clifford P; Singh S; Demissie A; Svedmyr A
    J Natl Cancer Inst; 1973 Jul; 51(1):45-56. PubMed ID: 4352753
    [No Abstract]   [Full Text] [Related]  

  • 22. Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt's lymphoma. Comparison of dying patients with long-term survivors.
    Henle W; Henle G; Gunvén P; Klein G; Clifford P; Singh S
    J Natl Cancer Inst; 1973 May; 50(5):1163-73. PubMed ID: 4351392
    [No Abstract]   [Full Text] [Related]  

  • 23. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.
    Baldwin RW; Price MR; Robins RA
    Nat New Biol; 1972 Aug; 238(84):185-6. PubMed ID: 4340574
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of local radiotherapy on the antibody levels against EBV-induced early and capsid antigens (EA and VCA) in patients with certain malignant tumours.
    Einhorn N; Henle G; Henle W; Klein G; Clifford P
    Int J Cancer; 1972 Jan; 9(1):182-92. PubMed ID: 4335641
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis.
    Henle W; Henle G; Niederman JC; Klemola E; Haltia K
    J Infect Dis; 1971 Jul; 124(1):58-67. PubMed ID: 4335450
    [No Abstract]   [Full Text] [Related]  

  • 26. Blocking of direct membrane immunofluorescence in titration of membrane-reactive antibodies associated with Epstein-Barr virus.
    Gunvén P; Klein G
    J Natl Cancer Inst; 1971 Sep; 47(3):539-48. PubMed ID: 4333666
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma.
    Henle G; Henle W; Klein G; Gunven P; Clifford P; Morrow RH; Ziegler JL
    J Natl Cancer Inst; 1971 Apr; 46(4):861-71. PubMed ID: 4324816
    [No Abstract]   [Full Text] [Related]  

  • 28. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.
    zur Hausen H; Schulte-Holthausen H; Klein G; Henle W; Henle G; Clifford P; Santesson L
    Nature; 1970 Dec; 228(5276):1056-8. PubMed ID: 4320657
    [No Abstract]   [Full Text] [Related]  

  • 29. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
    Gunvén P; Klein G; Henle G; Henle W; Clifford P
    Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
    [No Abstract]   [Full Text] [Related]  

  • 30. EB viral antigens in Burkitt tumor biopsies and early cultures.
    Nadkarni JS; Nadkarni JJ; Klein G; Henle W; Henle G; Clifford P
    Int J Cancer; 1970 Jul; 6(1):10-7. PubMed ID: 4319228
    [No Abstract]   [Full Text] [Related]  

  • 31. Direct membrane immunofluorescence reaction of Burkitt's lymphoma cells in culture.
    Goldstein G; Klein G; Pearson G; Clifford P
    Cancer Res; 1969 Apr; 29(4):749-52. PubMed ID: 4180347
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of Burkitt's lymphoma.
    Clifford P; Gripenberg U; Klein E; Fenyo EM; Manolov G
    Lancet; 1968 Aug; 2(7566):517-8. PubMed ID: 4174532
    [No Abstract]   [Full Text] [Related]  

  • 33. Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures.
    Klein G; Clifford P; Klein E; Smith RT; Minowada J; Kourilsky FM; Burchenal JH
    J Natl Cancer Inst; 1967 Nov; 39(5):1027-44. PubMed ID: 4169243
    [No Abstract]   [Full Text] [Related]  

  • 34. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.
    Reedman BM; Klein G
    Int J Cancer; 1973 May; 11(3):499-520. PubMed ID: 4133943
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between the EBV-associated membrane antigen on Burkitt lymphoma cells and the viral envelope, demonstrated by immunoferritin labelling.
    Silvestre D; Kourilsky FM; Klein G; Yata Y; Neauport-Sautes C; Levy JP
    Int J Cancer; 1971 Sep; 8(2):222-33. PubMed ID: 4109105
    [No Abstract]   [Full Text] [Related]  

  • 36. Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma.
    Gunvén P; Klein G; Clifford P; Singh S
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1422-6. PubMed ID: 4364538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus infection in relation to infectious mononucleosis and Burkitt's lymphoma.
    Smith RT; Bausher JC
    Annu Rev Med; 1972; 23():39-56. PubMed ID: 4345525
    [No Abstract]   [Full Text] [Related]  

  • 38. Epstein-barr-virus nuclear antigen.
    Vonka V; Hirsch I
    Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
    [No Abstract]   [Full Text] [Related]  

  • 39. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
    Henle W; Henle G
    Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
    [No Abstract]   [Full Text] [Related]  

  • 40. An assessment of the possible role of viruses in the aetiology of Burkitt's lymphoma.
    Epstein MA
    Prog Exp Tumor Res; 1978; 21():72-99. PubMed ID: 205908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.